Today: 12 May 2026
Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like
6 May 2026
2 mins read

Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like

NEW YORK, May 6, 2026, 11:01 EDT

  • Palantir stock dropped once more, even after topping quarterly estimates and hiking its 2026 outlook by a wide margin.
  • Valuation remained front and center for investors, with a minor U.S. commercial revenue shortfall drawing attention alongside the headline growth.
  • Bank of America kept its bullish stance, though it cautioned the stock faces a tough hurdle ahead.

Palantir Technologies shares dropped 1.4% to $134.04 late Wednesday morning, deepening a selloff that’s followed its recent earnings release. That’s even with the data analytics and AI software firm delivering its strongest revenue growth yet as a public company and upping its full-year forecast. The stock finished Tuesday at $135.91.

Palantir doesn’t have much margin for error here. Investors have pegged it as a top beneficiary of corporate and government AI budgets—yet that’s pushed the stock to a level where investors expect almost flawless execution.

Palantir reported first-quarter revenue of $1.63 billion, up 85% from a year earlier. U.S. revenue shot up even more, more than doubling to $1.28 billion. The company posted adjusted earnings per share of 33 cents—this measure excludes certain costs like stock-based compensation and related payroll taxes. On a GAAP basis, Palantir earned 34 cents per share.

Top-line numbers looked fine, but the revenue breakdown told a different story. U.S. commercial revenue jumped 133% to $595 million—just shy of the $605 million FactSet consensus. That slight miss was enough for traders to take profits after the stock’s extended rally.

Palantir bumped up its 2026 revenue outlook, raising the range to $7.65 billion to $7.66 billion—up from the earlier $7.18 billion to $7.20 billion band. The company is also projecting second-quarter revenue between $1.797 billion and $1.801 billion, topping analyst estimates of $1.68 billion, according to Reuters.

Alex Karp, the chief executive, emphasized Palantir’s U.S. momentum, calling the country “the center, the constant core, of our business” in a shareholder letter quoted by Reuters. “And that business is erupting,” he added. Reuters

Palantir got a boost from its government contracts. U.S. government revenue jumped 84% to $687 million, driven by heightened appetite for defense and intelligence software. Reuters reports the company’s Maven AI system—built for battlefield data analysis and target identification—is on track for designation as a Pentagon program of record, potentially locking in longer-term use for the U.S. military.

Palantir’s cash generation picked up as well. Operating cash flow landed at $899 million, with adjusted free cash flow coming in at $925 million. The company closed the quarter holding $8.0 billion in cash, cash equivalents, and short-term U.S. Treasury securities. Its Rule of 40 score—a key software benchmark combining revenue growth and adjusted operating margin—hit a hefty 145%.

Bank of America stuck with its Buy rating and $255 price target, describing the quarter as a “step-function” print, TheStreet reports. The firm bumped its 2026 sales projection up to $7.85 billion from $7.37 billion and lifted its 2026 EPS view to $1.47, previously $1.30. TheStreet

Even so, the stock faces a unique bar compared to other software peers. Matt Britzman, senior equity analyst at Hargreaves Lansdown, noted Palantir’s results highlighted solid demand and recurring revenue. But he cautioned that “expectations are sky high” and warned investors to brace for greater swings than they’d see in most tech names. Hargreaves Lansdown

There’s a risk AI software prices fall, or the tech becomes too easy to copy, or the field just gets packed. Bank of America, according to TheStreet, flagged concerns around Palantir’s pricing strength, slow public-sector uptake, and intensifying rivalry from OpenAI, Anthropic, and Meta—each one ramping up its AI efforts and threatening to erode Palantir’s lead.

Palantir’s growth keeps both bulls and bears on their toes, but Wednesday made the market’s stance clear. A beat and raise doesn’t cut it anymore—especially when investors have already priced that in.

Stock Market Today

  • QuantumScape Shares Rise 9.35% After Q1 Earnings Beat Expectations
    May 12, 2026, 5:51 PM EDT. QuantumScape Corporation (NASDAQ: QS) shares jumped 9.35% following its Q1 2026 earnings report, which showed a smaller-than-expected loss of $0.16 per share versus Wall Street's forecast of $0.18. Despite continuing losses of $100.8 million driven by heavy R&D spending, QS's strong cash position of $904.7 million and a working capital cushion of $872.1 million reassure investors. The stock's advance from mid-$6s in late April to around $8.26 on May 11 reflects growing optimism about the firm's solid-state lithium-metal battery technology. Market participants remain focused on progress toward commercialization, with robust trading momentum indicating confidence in QS's potential for electric vehicle applications.

Latest article

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

Camtek Stock Falls 16% After Earnings Beat as Margin Pressure and Hot CPI Hit AI Chip Trade

12 May 2026
Camtek shares fell 15.8% to $174.63 despite beating Q1 revenue and adjusted EPS estimates by small margins. Q1 revenue rose 2.5% year over year, but non-GAAP EPS dropped to $0.70 from $0.79 and operating margin narrowed to 25.5%. Management guided Q2 revenue to $129–$131 million and expects second-half revenue to rise over 25%. Broader market pressure followed a hot April CPI and rising Treasury yields.
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk

Oscar Health Stock Extends Post-Earnings Repricing as Margins Outweigh ACA Risk

12 May 2026
Oscar Health shares rose 7.9% to $23.73 late Tuesday, with volume near 13 million, after posting strong Q1 profit and lower claims costs despite missing revenue estimates. The company’s medical loss ratio fell to 70.5% from 75.4% a year earlier. Membership climbed to 3.17 million. ACA enrollment churn and policy risk remain concerns.
Arm Stock Surges Before Earnings as AI Server CPU Bet Faces Wall Street Test
Previous Story

Arm Stock Surges Before Earnings as AI Server CPU Bet Faces Wall Street Test

Why POET Technologies Stock Is Back in the Spotlight After Marvell Order Shock
Next Story

Why POET Technologies Stock Is Back in the Spotlight After Marvell Order Shock

Go toTop